‘Optimism on a vaccine has increased notably.’
Positive news surrounding the development of a vaccine for COVID-19 continues.
On Monday, The Lancet published promising results of a COVID-19 vaccine study by the University of Oxford and AstraZenaca. Pfizer and BioNTech also reported positive early data from their own COVID-19 vaccine study on Monday.
The market’s reaction to the news was muted, though a massive rally in tech stocks dragged all three major indexes to gains to start the week.
And the results of a recent survey from Deutsche Bank perhaps explain why investors did not take this news as a meaningful new catalyst for the market. Seeing these headlines instead as the kind of interim vaccine news that has increasingly been priced into stocks over the last few weeks.
In its latest monthly sentiment survey of 500 market professionals from around the globe, Deutsche Bank found that some 56% of respondents believe a vaccine will be available within a year.
The best of the Muslim Times’ collection for war against Covid 19:
In this day and age, understanding bacteria and viruses and developing vaccines are national security issues. In my view sizable part of every country’s defense budget should be spent in these pursuits rather than making tanks and other weapons.
For the latest news about drugs and vaccines’ trials please go to: Pharmaceutical-Technology
For the latest health news from BBC, Please click here
The Muslim Times has the best collections in the war against Covid 19 as we are collecting from all the established sources
For the number of cases and epidemiology in each country go to: WorldOMeters
DAILY NEW CASES AND DEATHS IN US, CDC SITE